Liposomes as drug carriers for oral ulcers.
The aim of this study was to test the potential of liposomes as drug carriers to the ulcerated oral mucosa. Radioactive triamcinolone acetonide palmitate (3H-TRMAp) was encapsulated in large multilamellar lipid vesicles and served as the test lotion. 3H-TRMAp in solution served as control. Forty-six hamsters were divided into three groups. In group I, multiple confluent ulcers in both cheek pouches were treated by topical application. In group II, single ulcers on the cheeks were treated by intramucosal injection. In group III, multiple confluent ulcers were produced in the cheek pouch on one side, with a single ulcer in the contralateral cheek pouch; no drug was applied, and the tissues were prepared for histology. Hamsters were killed at three and 24 hours, respectively, after treatment. Pouches were divided into ulcerated and intact adjacent mucosa. Cheeks were divided into ulcerated mucosa and distant mucosa. Drug levels in the four mucosal portions as well as in the blood, liver, spleen, brain, and thalamic region were determined by radioactive tracer technique. At three hours, liposomal drug concentrations were lower than in control animals in the brain and the thalamic region. At 24 hours, liposomal drug values were higher than in control animals in the ulcerated mucosa and lower than in control animals in the thalamic region. Mean drug concentrations in the ulcerated mucosa were higher in group II than group I. The results parallel those of Mezei and Gulasekharam (1980, 1982); liposomes increase local and decrease systemic drug concentration.(ABSTRACT TRUNCATED AT 250 WORDS)
Harsanyi
B B
BB
Hilchie
J C
JC
Mezei
M
M
D000287:Administration, Topical; D000818:Animals; D002058:Burns, Electric / Q000188:drug therapy / Q000378:metabolism; D006224:Cricetinae; D007267:Injections; D008081:Liposomes / Q000008:administration & dosage*; D009059:Mouth Diseases / Q000188:drug therapy* / Q000378:metabolism; D014222:Triamcinolone Acetonide / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000378:metabolism / Q000627:therapeutic use; D014316:Tritium; D014456:Ulcer / Q000188:drug therapy / Q000378:metabolism
D008081:Liposomes; D014316:Tritium; C041990:triamcinolone acetonide 21-palmitate; D014222:Triamcinolone Acetonide